Avery W Catlin is Director of Provention Bio, Inc.. Currently has a direct ownership of 10,000 shares of PRVB, which is worth approximately $0. The most recent transaction as insider was on Apr 13, 2023, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
0% 12M change
Total Value Held $0

AVERY W CATLIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 13 2023
SELL
Bona fide gift
-
10,000 Reduced 50.0%
10,000 Common Stock

Also insider at

CRBP
Corbus Pharmaceuticals Holdings, Inc. Healthcare
AWC

Avery W Catlin

Director
Red Bank, NJ

Track Institutional and Insider Activities on PRVB

Follow Provention Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRVB shares.

Notify only if

Insider Trading

Get notified when an Provention Bio, Inc. insider buys or sells PRVB shares.

Notify only if

News

Receive news related to Provention Bio, Inc.

Track Activities on PRVB